ClinicalTrials.Veeva

Menu

Fitting Evaluation of Hydrogel and Silicone Hydrogel Sphere Design Contact Lenses

CooperVision logo

CooperVision

Status

Completed

Conditions

Myopia

Treatments

Device: Omafilcon A
Device: Somofilcon A
Device: Omafilcon A - Proclear (PC)

Study type

Interventional

Funder types

Industry

Identifiers

NCT03098745
EX-MKTG-79

Details and patient eligibility

About

The aim of this non-dispensing fitting study is to evaluate the short term lens fit, vision performance of three monthly replacement sphere lenses.

Full description

This is a 40-subject, double masked, randomized, bilateral, non-dispensing fitting trial comparing hydrogel and silicone hydrogel lens materials. It is anticipated that this study will involve 2 visits for each lens pair, as follows: Visits: V1 (lens dispensing), V2 (1 hour post lens settling). Each subject will be randomized to wear each pair bilaterally in a series of three short fitting comparisons.

Enrollment

40 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • A person is eligible for inclusion in the study if he/she:

    • Is between 18 and 40 years of age (inclusive).
    • Has had a self-reported visual exam in the last two years.
    • Is an adapted soft CL (Contact Lens) wearer who is not wearing any of the study lenses.
    • Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)
    • Has a spectacle cylinder up to 0.75D (Diopter) in each eye.
    • Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
    • Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
    • Has clear corneas and no active ocular disease.
    • Has read, understood and signed the information consent letter.
    • Patient contact lens refraction should fit within the available parameters of the study lenses.
    • Is willing to comply with the wear schedule.
    • Is willing to comply with the visit schedule.

Exclusion criteria

  • A person will be excluded from the study if he/she:

    • Has never worn contact lenses before.

    • Currently wears rigid gas permeable contact lenses.

    • Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)

    • Has a CL prescription outside the range of - 1.00 to - 6.00D

    • Has a spectacle cylinder ≥1.00D of cylinder in either eye.

    • Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.

    • Presence of clinically significant (grade 2-4) anterior segment abnormalities.

    • Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.

    • Slit lamp findings that would contraindicate contact lens wear such as:

      • Pathological dry eye or associated findings
      • Pterygium, pinguecula, or corneal scars within the visual axis
      • Neovascularization > 0.75 mm in from of the limbus
      • Giant papillary conjunctivitis (GCP) worse than grade 1
      • Anterior uveitis or iritis (past or present)
      • Seborrheic eczema, Seborrheic conjunctivitis
      • History of corneal ulcers or fungal infections
      • Poor personal hygiene
    • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

    • Has aphakia, keratoconus or a highly irregular cornea.

    • Has Presbyopia or has dependence on spectacles for near work over the contact lenses.

    • Has undergone corneal refractive surgery.

    • Is participating in any other type of eye related clinical or research study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

40 participants in 3 patient groups

Omafilcon A
Active Comparator group
Description:
Participants are randomized to wear omafilcon A lens pair bilaterally for 1 hour during the study.
Treatment:
Device: Omafilcon A
Somofilcon A
Active Comparator group
Description:
Participants are randomized to wear somofilcon A lens pair bilaterally for 1 hour during the study.
Treatment:
Device: Somofilcon A
Omafilcon A - Proclear (PC)
Active Comparator group
Description:
Participants are randomized to wear omafilcon A - PC lens pair bilaterally for 1 hour during the study.
Treatment:
Device: Omafilcon A - Proclear (PC)

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems